News

Researchers have now discovered that a gene called GLIS1 that will help target ways to prevent or slow down the progression of glaucoma.

Astrocyte Pharmaceuticals Inc. announces that it has received a $500,000 award jointly funded by the Medical Technology Enterprise Consortium (MTEC) and the BrightFocus Foundation.

In this issue: Deciphering the Alzheimer's Disease Glyco-Code, Restoring Immune Function to Treat Alzheimer's, "Zinc Fingers" Gene Therapy Reduces Toxic Tau in Mice, and more!

Researchers find that stimulating a surface structure on neurons clears tau tangles, lessens disease effects, and improves memory, suggesting a possible new treatment.

BrightFocus is funding early science behind a promising new technology– a wearable device that provides a very early prediction of Alzheimer’s onset.

Researchers uncover a potential association between an APOE genetic variant and changes in brain metabolism leading to increased risk of Alzheimer’s disease and cognitive impairment.